MedTrace Logo

Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214

NCT01458899 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2012-01-11

No results posted yet for this study

Summary

(Food versus no food) crossover study to measure the effects of food on pharmacokinetics of TC-5214 (S-Mecamylamine) in healthy Subjects.

Conditions

  • Healthy Subjects

Interventions

DRUG

TC-5214

Oral tablets, single 4mg dose

Sponsors & Collaborators

Principal Investigators

  • Hans A Eriksson, MD · AstraZeneca Kvambergagatan 12, 15185, Sodertalje, Sweden

  • David Mathews, MD · Quintiles, Inc. Overland Park US

  • Brendan Smyth, MD · AstraZeneca 180 Concord Pike Wilmington, DE 19850-5437

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01458899 on ClinicalTrials.gov